Zhejiang Key Laboratory of Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, 310022, China.
The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, 310053, China.
BMC Cancer. 2023 Oct 17;23(1):988. doi: 10.1186/s12885-023-11499-6.
The machine learning models with dose factors and the deep learning models with dose distribution matrix have been used to building lung toxics models for radiotherapy and achieve promising results. However, few studies have integrated clinical features into deep learning models. This study aimed to explore the role of three-dimension dose distribution and clinical features in predicting radiation pneumonitis (RP) in esophageal cancer patients after radiotherapy and designed a new hybrid deep learning network to predict the incidence of RP.
A total of 105 esophageal cancer patients previously treated with radiotherapy were enrolled in this study. The three-dimension (3D) dose distributions within the lung were extracted from the treatment planning system, converted into 3D matrixes and used as inputs to predict RP with ResNet. In total, 15 clinical factors were normalized and converted into one-dimension (1D) matrixes. A new prediction model (HybridNet) was then built based on a hybrid deep learning network, which combined 3D ResNet18 and 1D convolution layers. Machine learning-based prediction models, which use the traditional dosiomic factors with and without the clinical factors as inputs, were also constructed and their predictive performance compared with that of HybridNet using tenfold cross validation. Accuracy and area under the receiver operator characteristic curve (AUC) were used to evaluate the model effect. DeLong test was used to compare the prediction results of the models.
The deep learning-based model achieved superior prediction results compared with machine learning-based models. ResNet performed best in the group that only considered dose factors (accuracy, 0.78 ± 0.05; AUC, 0.82 ± 0.25), whereas HybridNet performed best in the group that considered both dose factors and clinical factors (accuracy, 0.85 ± 0.13; AUC, 0.91 ± 0.09). HybridNet had higher accuracy than that of Resnet (p = 0.009).
Based on prediction results, the proposed HybridNet model could predict RP in esophageal cancer patients after radiotherapy with significantly higher accuracy, suggesting its potential as a useful tool for clinical decision-making. This study demonstrated that the information in dose distribution is worth further exploration, and combining multiple types of features contributes to predict radiotherapy response.
机器学习模型与剂量因子以及深度学习模型与剂量分布矩阵已被用于构建放疗中的肺毒性模型,并取得了有前景的结果。然而,很少有研究将临床特征整合到深度学习模型中。本研究旨在探索三维剂量分布和临床特征在预测放疗后食管癌患者放射性肺炎(RP)中的作用,并设计了一种新的混合深度学习网络来预测 RP 的发生率。
本研究共纳入 105 例接受放疗的食管癌患者。从治疗计划系统中提取肺部的三维(3D)剂量分布,转换为 3D 矩阵,并将其用作 ResNet 预测 RP 的输入。共有 15 个临床因素被归一化并转换为一维(1D)矩阵。然后,基于混合深度学习网络,构建了一个新的预测模型(HybridNet),该网络结合了 3D ResNet18 和 1D 卷积层。还构建了基于机器学习的预测模型,这些模型使用传统的剂量矩阵和包含或不包含临床因素作为输入,并使用十折交叉验证比较了这些模型与 HybridNet 的预测性能。使用准确率和受试者工作特征曲线下的面积(AUC)来评估模型效果。使用 DeLong 检验比较了模型的预测结果。
基于深度学习的模型比基于机器学习的模型具有更好的预测结果。在仅考虑剂量因素的组中,ResNet 表现最佳(准确率为 0.78±0.05;AUC 为 0.82±0.25),而在同时考虑剂量因素和临床因素的组中,HybridNet 表现最佳(准确率为 0.85±0.13;AUC 为 0.91±0.09)。HybridNet 的准确率高于 Resnet(p=0.009)。
基于预测结果,所提出的 HybridNet 模型可以更准确地预测放疗后食管癌患者的 RP,表明其有潜力成为临床决策的有用工具。本研究表明,剂量分布中的信息值得进一步探索,结合多种类型的特征有助于预测放疗反应。